Hikma Pharmaceuticals - Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Registrars:

Key Personnel

CEO: Said Darwazah
Chairman: Victoria Hull
Deputy CEO: Khalid Nabilsi
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Cynthia Schwalm, Laura Balan Balan, Deneen Vojta, Tobias Hestler
Non-Executive Director: Ali Al-Husry
Senior Independent Director: Douglas Hurt

Contact Details

Address: 10 Portman Square, London, United Kingdom
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com
Email:

Listings

ISIN: GB00B0LCW083
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE 250, FTSE 350, FTSE All-Share